ALK-Abelló A/S (AKBLF)
OTCMKTS
· Delayed Price · Currency is USD
21.35
+1.05 (5.17%)
At close: Feb 11, 2025
ALK-Abelló Revenue
In the year 2024, ALK-Abelló had annual revenue of 5.54B DKK with 14.78% growth. ALK-Abelló had revenue of 1.50B in the quarter ending December 31, 2024, with 11.45% growth.
Revenue
5.54B DKK
Revenue Growth
+14.78%
P/S Ratio
n/a
Revenue / Employee
2.01M DKK
Employees
2,753
Market Cap
4.46B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.54B | 713.00M | 14.78% |
| Dec 31, 2023 | 4.82B | 313.00M | 6.94% |
| Dec 31, 2022 | 4.51B | 595.00M | 15.19% |
| Dec 31, 2021 | 3.92B | 425.00M | 12.17% |
| Dec 31, 2020 | 3.49B | 217.00M | 6.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.18B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
ALK-Abelló News
- 22 days ago - ALK-Abelló projects 9%-13% revenue growth for 2025 driven by global tablet expansion - Seeking Alpha
- 22 days ago - ALK-Abelló A/S (AKBLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - ALK-Abelló A/S reports FY results - Seeking Alpha
- 4 months ago - Q3 2024 ALK-Abello A/S Earnings Call Transcript - GuruFocus
- 4 months ago - ALK-Abelló A/S (AKBLF) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 4 months ago - ALK-Abelló A/S 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - ALK-Abelló A/S 2024 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - ALK-Abelló A/S (AKBLF) Q2 2024 Earnings Call Transcript - Seeking Alpha